BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14982829)

  • 1. Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.
    Nixon RA
    Am J Pathol; 2004 Mar; 164(3):757-61. PubMed ID: 14982829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities.
    Jin LW; Shie FS; Maezawa I; Vincent I; Bird T
    Am J Pathol; 2004 Mar; 164(3):975-85. PubMed ID: 14982851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.
    Nixon RA
    FASEB J; 2017 Jul; 31(7):2729-2743. PubMed ID: 28663518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol and tau protein--findings in Alzheimer's and Niemann Pick C's disease.
    Ohm TG; Treiber-Held S; Distl R; Glöckner F; Schönheit B; Tamanai M; Meske V
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S120-6. PubMed ID: 14574625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retromers in Alzheimer's disease.
    Siegenthaler BM; Rajendran L
    Neurodegener Dis; 2012; 10(1-4):116-21. PubMed ID: 22398391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study.
    Mattsson N; Zetterberg H; Bianconi S; Yanjanin NM; Fu R; Månsson JE; Porter FD; Blennow K
    Neurology; 2011 Jan; 76(4):366-72. PubMed ID: 21205675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol in Alzheimer's disease and tauopathy.
    Burns M; Duff K
    Ann N Y Acad Sci; 2002 Nov; 977():367-75. PubMed ID: 12480774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
    Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GGA1 overexpression attenuates amyloidogenic processing of the amyloid precursor protein in Niemann-Pick type C cells.
    Kosicek M; Wunderlich P; Walter J; Hecimovic S
    Biochem Biophys Res Commun; 2014 Jul; 450(1):160-5. PubMed ID: 24866237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional links between Alzheimer's disease and Niemann-Pick type C disease.
    Malnar M; Hecimovic S; Mattsson N; Zetterberg H
    Neurobiol Dis; 2014 Dec; 72 Pt A():37-47. PubMed ID: 24907492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis.
    Tan J; Evin G
    J Neurochem; 2012 Mar; 120(6):869-80. PubMed ID: 22171895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorting receptor SORLA--a trafficking path to avoid Alzheimer disease.
    Willnow TE; Andersen OM
    J Cell Sci; 2013 Jul; 126(Pt 13):2751-60. PubMed ID: 23813966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.
    Cataldo A; Rebeck GW; Ghetri B; Hulette C; Lippa C; Van Broeckhoven C; van Duijn C; Cras P; Bogdanovic N; Bird T; Peterhoff C; Nixon R
    Ann Neurol; 2001 Nov; 50(5):661-5. PubMed ID: 11706973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells.
    Yamazaki T; Chang TY; Haass C; Ihara Y
    J Biol Chem; 2001 Feb; 276(6):4454-60. PubMed ID: 11085995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin.
    Maulik M; Ghoshal B; Kim J; Wang Y; Yang J; Westaway D; Kar S
    Hum Mol Genet; 2012 Nov; 21(22):4857-75. PubMed ID: 22869680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
    Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
    Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.